US: High demand for safe rheumatoid arthritis treatment to cause increased drug pipeline

June 28, 2011 - PRLog -- According to the report ‘U.S. Rheumatoid Arthritis Market: Assessment of Biologics and New Treatments’ now available at http://www.pharmaceutical-market-research.com/go/FRS02259 high demand for safe rheumatoid arthritis (RA) treatment to grow the pipeline for drugs. Owing to the unmet requirement for a suitable, safe rheumatoid arthritis treatment choice without unpleasant side effects, a flurry of new drug launches in the near future is imminent.

As a result of this demand, some of the current pipeline drugs have the potential to be blockbusters, especially the oral treatments in late-stage development. In 2010, the American College of Rheumatology and the European League against Rheumatism revised the 1987 classification criteria for RA to enable early detection. The new classification facilitates diagnosing RA patients and thereby, gives a boost to the treatment market.

Read more here:  http://www.pharmaceutical-market-research.com/publications/treatments/u_s_rheumatoid_arthritis_market_assessment_biologics_new_treatments.html Pharmaceutical-market-research.com is the source for information products concerning the global biotechnology, healthcare, medical device and pharmaceutical industries. With over 20,000 market reports available, executives can find a current and comprehensive range of specialised intelligence. www.pharmaceutical-market-research.com is a service from Piribo Ltd, which was founded in 2004.

# # #

About Piribo.
Piribo http:www.piribo.com is the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books.